Reproduction permitted for personal use only. For reprints and reprint permission, contact firstname.lastname@example.org.
Bone Care, a UW-Madison spinoff that develops a drug for kidney-disease patients, is being acquired for $600 million. The buyer? Massachusetts-based Genzyme, a multi-billion-dollar biotech. Also: the Wisconsin Angel Network gives entrepreneurs and angel investors a new way to find each other, and UW-Madison reviews desktop search engines.
Original air date: Saturday, May 7, 2005